• Colin

Now Accepting Applications: Applied Pharmacometrics Training Fellowship - Africa

Applied Pharmacometrics Training fellowship continues into the second year – Apply by 15 October 2022!

CP+ Associates is pleased to announce the continuation of its Applied Pharmacometrics Training (APT) fellowship program for doctoral-level scientists from Africa, in partnership with Pharmacometrics Africa, Certara, Inc, and other industry and academic partners. After its successful first year with sixteen fellows, the program has opened the call for applications for its second cohort.


The APT in Africa is comprised of a 3-month virtual program that provides fellows with training to conduct regulatory-quality pharmacometrics analyses and reports. Afterward, fellows can continue for another 3 months in an immersion program where they conduct a data analysis project leading to a publishable unit, under the supervision of subject matter experts. The second cohort will begin the virtual program of the fellowship in January 2023.

“I am thrilled with the engagement and progress of the first cohort of scientists – this has exceeded our initial expectations. I encourage recent doctorate graduates who have completed core training in pharmacometrics and who want to apply quantitative approaches to benefit drug development and clinical practice in Africa to consider applying.”
Colin Pillai, Ph.D., CEO of Pharmacometrics Africa and CEO of CP+ Associates.

The fellowship program is accepting applications now. To learn more or apply, please visit the application site. The application phase will close on 15 October 2022.


“We are looking forward to welcoming the second cohort of fellows and are excited to continue advancing our goal of expanding scientific and leadership capabilities in Africa in model-informed drug development,” said “The APT fellows from the first cohort, who are joining the hybrid immersion program, are meeting in Cape Town, South Africa to participate in workshops, where they will delve into the data analysis projects that have been set up by our industry and academic partners.”
Rik de Greef senior vice president of global quantitative science services at Certara.

About CP+ Associates

CP+ Associates was established in 2017 as a social venture that develops scientific capability in low- and middle-income countries (LMIC), focusing on healthcare via drug discovery, development science and clinical trials.


About Pharmacometrics Africa

Pharmacometrics Africa is a not-for-profit company registered in South Africa as a platform for interested groups to establish and run open access quantitative clinical pharmacology educational programs in partnership with local research organizations and academic groups.


Pharmacometrics Africa and CP+ Associates Contact:

Rita Michel rita@cpplusassociates.org



About Certara

Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries.


Certara Contact:

Jieun Choe Chief Strategy and Marketing Officer jieun.choe@certara.com

0 comments

Recent Posts

See All

WCoP 2020 HAS BEEN POSTPONED INTO 2021 Because of the global coronavirus emergency, the WCoP organising committee has decided to take the difficult decision of postponing WCoP to 2021. The majority of